Abstract
Pediatric heart disease is a large and diverse field with an overall prevalence estimated at 6 to 13 per 1,000 live births. This document discusses appropriateness of advanced imaging for a broad range of variants. Diseases covered include tetralogy of Fallot, transposition of great arteries, congenital or acquired pediatric coronary artery abnormality, single ventricle, aortopathy, anomalous pulmonary venous return, aortopathy and aortic coarctation, with indications for advanced imaging spanning the entire natural history of the disease in children and adults, including initial diagnosis, treatment planning, treatment monitoring, and early detection of complications. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S351-S381 |
| Journal | Journal of the American College of Radiology |
| Volume | 20 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2023 |
Funding
Dr Abbara reports royalties or licenses from Eslevier - royalties for textbooks and lead author role; leadership roles as BOD SCCT, Editor in Chief for RSNA journal (Radiology Cardiothoracic Imaging. Dr Brown reports participation on an advisory board for Covera Health. Dr Chan reports grants or contracts from Jazz pharmaceuticals, GE healthcare, Hyperfine Inc; consulting fees from Jazz pharmaceuticals; payments or honoraria from Jazz pharmaceuticals; support for meetings from Jazz pharmaceuticals; patents from Children's Mercy Kansas City; leadership roles as Vice Chair at Children's Mercy Kansas City; Director of Research, UMKC School of Medicine; ACR Pediatric Research Committee Co-Chair. Dr Hanneman reports payments or honoraria from Sanofi; leadership roles as Associate editor Radiology and Radiology Cardiothoracic Imaging. Dr Rajiah reports royalties or licenses from Elsevier- authoring/editing. Dr Samyn reports grants or contracts from NIH R01 HL 164995-02 Predictive modeling of acute rejection in pediatric heart transplant recipients; payments or honoraria from Honorarium for speaking at Additional Ventures Single Ventricle Symposium in Baltimore MD (October 2022); support for meetings from Medical College of Wisconsin Travel grant for travel to International Society of Magnetic Resonance in Medicine (ISMRM) meeting in Toronto 2023; leadership roles as Unpaid board member for the College of Engineering and Science at University of Detroit Mercy. Dr Wall reports leadership roles as Board Member of the Washington Chapter of the American College of Emergency Medicine. All other authors state that they have no conflict of interest related to the material discussed in this article. Drs Hanneman and Hsu are partners, and the other authors are non-partner/non-partnership track/employees. Dr Abbara reports royalties or licenses from Eslevier - royalties for textbooks and lead author role; leadership roles as BOD SCCT, Editor in Chief for RSNA journal (Radiology Cardiothoracic Imaging. Dr Brown reports participation on an advisory board for Covera Health. Dr Chan reports grants or contracts from Jazz pharmaceuticals, GE healthcare, Hyperfine Inc; consulting fees from Jazz pharmaceuticals; payments or honoraria from Jazz pharmaceuticals; support for meetings from Jazz pharmaceuticals; patents from Children's Mercy Kansas City; leadership roles as Vice Chair at Children's Mercy Kansas City; Director of Research, UMKC School of Medicine; ACR Pediatric Research Committee Co-Chair. Dr Hanneman reports payments or honoraria from Sanofi; leadership roles as Associate editor Radiology and Radiology Cardiothoracic Imaging. Dr Rajiah reports royalties or licenses from Elsevier- authoring/editing. Dr Samyn reports grants or contracts from NIH R01 HL 164995-02 Predictive modeling of acute rejection in pediatric heart transplant recipients; payments or honoraria from Honorarium for speaking at Additional Ventures Single Ventricle Symposium in Baltimore MD (October 2022); support for meetings from Medical College of Wisconsin Travel grant for travel to International Society of Magnetic Resonance in Medicine (ISMRM) meeting in Toronto 2023; leadership roles as Unpaid board member for the College of Engineering and Science at University of Detroit Mercy. Dr Wall reports leadership roles as Board Member of the Washington Chapter of the American College of Emergency Medicine. All other authors state that they have no conflict of interest related to the material discussed in this article. Drs Hanneman and Hsu are partners, and the other authors are non-partner/non-partnership track/employees.
Keywords
- AUC
- Appropriateness Criteria
- anomalous pulmonary venous return
- aortopathy
- appropriate use criteria
- arterial switch operation
- atrial switch operation
- coarctation
- congenital heart disease
- connective tissue disease
- coronary artery
- imaging
- pediatric heart disease
- single ventricle
- tetralogy of Fallot
- transposition of great arteries
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging